Notice of Special Interest (NOSI): Exploratory Cancer Immunology Projects and Technologies (ExCITe)
National Institutes of Health
Description
The National Cancer Institute (NCI) is inviting applications for R21 grants aimed at high-risk, high-reward research in cancer immunology. The goal is to explore new ideas or technologies that could enhance our understanding of immune responses, tumor-immune interactions, and immune networks related to cancer. These projects should be innovative and different from typical R01 projects, with the potential to make significant breakthroughs in cancer immunology and treatment.
The National Cancer Institute (NCI) is encouraging R21 applications for innovative high-risk/high-reward research projects in cancer immunology. The focus is on novel hypotheses or technologies to advance understanding of cancer immunology, including immune responses, tumor-immune ecosystems, an…
Source
Grant ID
NOT-CA-24-016
Agency
National Institutes of Health
Subcategory/Subagency
National Cancer Institute
Key Dates
Opportunity Released
December 5, 2023
Eligibility
The following categories of applicants are invited to apply:
- Higher Education Institutions — Public/State-controlled Institutions of Higher Education
- Higher Education Institutions — Private Institutions of Higher Education
- Nonprofit Organizations with 501(c)(3) status (other than Institutions of Higher Education)
- Nonprofit Organizations without 501(c)(3) status (other than Institutions of Higher Education)
- For-Profit Organizations (other than Small Businesses)
- Small Businesses
- State Governments
- County Governments
- City or Township Governments
- Special District Governments
- Independent School Districts
- Public Housing Authorities/Indian Housing Authorities
- Native American Tribal Governments (Federally recognized)
- Native American Tribal Governments (Other than Federally recognized)
- Native American Tribal Organizations (other than Federally recognized Tribal Governments)
- U.S. Territories or Possessions
- Eligible Agencies of the Federal Government
- Regional Organizations
- Faith-based Organizations
- Non-domestic (non-U.S.) components of U.S. Organizations — as allowed by the parent NOFOs
- Community-based Organizations
- Foreign/Non-domestic Entities (Foreign Institutions) — as allowed by the parent NOFOs (PA-20-195, PA-20-196)
- Foreign components of U.S. projects — as allowed by the parent NOFOs
Similar opportunities
- Exploratory/Developmental Research Grant Program (R21)
National Institutes of Health
- NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
Department of Health and Human Services
- Notice of Funding Opportunity Purpose
National Institutes of Health
- Toward Translation of Cancer Nanotechnology Interventions (TTNCI)
National Institutes of Health
- Exploratory Research Projects for Innovative Molecular Analysis Technologies in Cancer Research
National Institutes of Health